These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 9109096)

  • 61. The CroRS two-component regulatory system is required for intrinsic beta-lactam resistance in Enterococcus faecalis.
    Comenge Y; Quintiliani R; Li L; Dubost L; Brouard JP; Hugonnet JE; Arthur M
    J Bacteriol; 2003 Dec; 185(24):7184-92. PubMed ID: 14645279
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Isolation of glycopeptide resistant Streptococcus gallolyticus strains with vanA, vanB, and both vanA and vanB genotypes from faecal samples of veal calves in The Netherlands.
    Mevius D; Devriese L; Butaye P; Vandamme P; Verschure M; Veldman K
    J Antimicrob Chemother; 1998 Aug; 42(2):275-6. PubMed ID: 9738855
    [No Abstract]   [Full Text] [Related]  

  • 63. Glycopeptide derivatives.
    Malabarba A; Ciabatti R
    Curr Med Chem; 2001 Dec; 8(14):1759-73. PubMed ID: 11562292
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Structural and functional characterization of VanG D-Ala:D-Ser ligase associated with vancomycin resistance in Enterococcus faecalis.
    Meziane-Cherif D; Saul FA; Haouz A; Courvalin P
    J Biol Chem; 2012 Nov; 287(45):37583-92. PubMed ID: 22969085
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Inducible, transferable resistance to vancomycin in Enterococcus faecalis A256.
    Shlaes DM; Bouvet A; Devine C; Shlaes JH; al-Obeid S; Williamson R
    Antimicrob Agents Chemother; 1989 Feb; 33(2):198-203. PubMed ID: 2497704
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Combating vancomycin resistance in bacteria: targeting the D-ala-D-ala dipeptidase VanX.
    Crowder MW
    Infect Disord Drug Targets; 2006 Jun; 6(2):147-58. PubMed ID: 16789876
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Alterations in peptidoglycan precursors and vancomycin susceptibility in Tn917 insertion mutants of Enterococcus faecalis 221.
    Handwerger S
    Antimicrob Agents Chemother; 1994 Mar; 38(3):473-5. PubMed ID: 8203839
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The cytoplasmic peptidoglycan precursor of vancomycin-resistant Enterococcus faecalis terminates in lactate.
    Handwerger S; Pucci MJ; Volk KJ; Liu J; Lee MS
    J Bacteriol; 1992 Sep; 174(18):5982-4. PubMed ID: 1522072
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Inducible and constitutive expression of resistance to glycopeptides and vancomycin dependence in glycopeptide-resistant Enterococcus avium.
    Rosato A; Pierre J; Billot-Klein D; Buu-Hoi A; Gutmann L
    Antimicrob Agents Chemother; 1995 Apr; 39(4):830-3. PubMed ID: 7785979
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Enterococcal resistance to vancomycin and related cyclic glycopeptide antibiotics.
    Shlaes DM; Binczewski B
    Eur J Clin Microbiol Infect Dis; 1990 Feb; 9(2):106-10. PubMed ID: 2318215
    [TBL] [Abstract][Full Text] [Related]  

  • 71. 19F NMR in the measurement of binding affinities of chloroeremomycin to model bacterial cell-wall surfaces that mimic VanA and VanB resistance.
    Entress RM; Dancer RJ; O'Brien DP; Try AC; Cooper MA; Williams DH
    Chem Biol; 1998 Jun; 5(6):329-37. PubMed ID: 9653551
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Comparison of the target sites and mechanisms of action of glycopeptide and lipoglycodepsipeptide antibiotics.
    Reynolds PE; Somner EA
    Drugs Exp Clin Res; 1990; 16(8):385-9. PubMed ID: 2151441
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Targeted elimination of Vancomycin resistance gene vanA by CRISPR-Cas9 system.
    Tao S; Hu C; Fang Y; Zhang H; Xu Y; Zheng L; Chen L; Liang W
    BMC Microbiol; 2023 Dec; 23(1):380. PubMed ID: 38049763
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Bacillus subtilis as a platform for molecular characterisation of regulatory mechanisms of Enterococcus faecalis resistance against cell wall antibiotics.
    Fang C; Stiegeler E; Cook GM; Mascher T; Gebhard S
    PLoS One; 2014; 9(3):e93169. PubMed ID: 24676422
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Cloning and heterospecific expression of the resistance determinant vanA encoding high-level resistance to glycopeptides in Enterococcus faecium BM4147.
    Brisson-Noël A; Dutka-Malen S; Molinas C; Leclercq R; Courvalin P
    Antimicrob Agents Chemother; 1990 May; 34(5):924-7. PubMed ID: 2360831
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Resistance to glycopeptide antibiotics. New horizons and problems].
    Egorov AM; Sazykin IuO
    Antibiot Khimioter; 2001; 46(6):3-5. PubMed ID: 11573322
    [No Abstract]   [Full Text] [Related]  

  • 77. DdlN from vancomycin-producing Amycolatopsis orientalis C329.2 is a VanA homologue with D-alanyl-D-lactate ligase activity.
    Marshall CG; Wright GD
    J Bacteriol; 1998 Nov; 180(21):5792-5. PubMed ID: 9791137
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Glycopeptide sulfation evades resistance.
    Kalan L; Perry J; Koteva K; Thaker M; Wright G
    J Bacteriol; 2013 Jan; 195(1):167-71. PubMed ID: 23104813
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Screening systems for detecting inhibitors of cell wall transglycosylation in Enterococcus. Cell wall transglycosylation inhibitors in Enterococcus.
    Mani N; Sancheti P; Jiang ZD; McNaney C; DeCenzo M; Knight B; Stankis M; Kuranda M; Rothstein DM
    J Antibiot (Tokyo); 1998 May; 51(5):471-9. PubMed ID: 9666175
    [TBL] [Abstract][Full Text] [Related]  

  • 80. A Transposon Screen Identifies Genetic Determinants of Vibrio cholerae Resistance to High-Molecular-Weight Antibiotics.
    Dörr T; Delgado F; Umans BD; Gerding MA; Davis BM; Waldor MK
    Antimicrob Agents Chemother; 2016 Aug; 60(8):4757-63. PubMed ID: 27216069
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.